Technical Analysis for EIGR - Eiger BioPharmaceuticals, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 5.11 | -0.58% | -0.03 |
EIGR closed down 0.58 percent on Monday, March 18, 2024, on 1.8 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bears made the stock sink to a new 52-week low. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
New 52 Week Closing Low | Bearish | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Narrow Range Bar | Range Contraction | 0.00% | |
New 52 Week Low | Weakness | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Down 3 Days in a Row | Weakness | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
New 52 Week Closing Low | Bearish | -0.58% | |
Earnings Movers | Other | -0.58% | |
Wide Bands | Range Expansion | -0.58% |
Alert | Time |
---|---|
Up 5% | about 9 hours ago |
Up 3% | about 9 hours ago |
Up 2% | about 9 hours ago |
Possible NR7 | about 10 hours ago |
Possible Inside Day | about 10 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/14/2024
Eiger BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops a portfolio of late-stage drugs for orphan diseases. It offers Sarasar, which is used for the treatment of hepatitis delta; Exendin that is used for the treatment of hypoglycemia; and Bestatin, which is used for the treatment of pulmonary arterial hypertension and lymphedema. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is based in Palo Alto, California.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Pharmacy Hypertension Hepatitis Specialty Drugs Pulmonary Arterial Hypertension Orphan Disease Pulmonary Hypertension Treatment Of Hepatitis Lymphedema Hypoglycemia
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Life Sciences Pharmacy Hypertension Hepatitis Specialty Drugs Pulmonary Arterial Hypertension Orphan Disease Pulmonary Hypertension Treatment Of Hepatitis Lymphedema Hypoglycemia
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 43.35 |
52 Week Low | 5.1 |
Average Volume | 8,449 |
200-Day Moving Average | 13.66 |
50-Day Moving Average | 6.29 |
20-Day Moving Average | 6.05 |
10-Day Moving Average | 6.21 |
Average True Range | 0.70 |
RSI (14) | 37.89 |
ADX | 23.24 |
+DI | 17.28 |
-DI | 21.06 |
Chandelier Exit (Long, 3 ATRs) | 6.15 |
Chandelier Exit (Short, 3 ATRs) | 7.21 |
Upper Bollinger Bands | 7.32 |
Lower Bollinger Band | 4.78 |
Percent B (%b) | 0.13 |
BandWidth | 42.06 |
MACD Line | -0.19 |
MACD Signal Line | -0.06 |
MACD Histogram | -0.13 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 5.63 | ||||
Resistance 3 (R3) | 5.69 | 5.57 | 5.55 | ||
Resistance 2 (R2) | 5.57 | 5.43 | 5.54 | 5.52 | |
Resistance 1 (R1) | 5.34 | 5.35 | 5.28 | 5.28 | 5.49 |
Pivot Point | 5.22 | 5.22 | 5.19 | 5.19 | 5.22 |
Support 1 (S1) | 4.99 | 5.09 | 4.93 | 4.94 | 4.73 |
Support 2 (S2) | 4.87 | 5.00 | 4.84 | 4.70 | |
Support 3 (S3) | 4.64 | 4.87 | 4.68 | ||
Support 4 (S4) | 4.59 |